Michael Brennan to Placebos
This is a "connection" page, showing publications Michael Brennan has written about Placebos.
Connection Strength
0.257
-
Brennan MT, Kent ML, Fox PC, Norton HJ, Lockhart PB. The impact of oral disease and nonsurgical treatment on bacteremia in children. J Am Dent Assoc. 2007 Jan; 138(1):80-5.
Score: 0.074
-
Brennan MT, Runyon MS, Batts JJ, Fox PC, Kent ML, Cox TL, Norton HJ, Lockhart PB. Odontogenic signs and symptoms as predictors of odontogenic infection: a clinical trial. J Am Dent Assoc. 2006 Jan; 137(1):62-6.
Score: 0.069
-
Brennan MT, Sasser HC, Fox PC, Lockhart PB. Statistical analysis used in "A prospective placebo-controlled double-blind trial of antibiotic prophylaxis in intraoral bone grafting procedures: a pliot study". Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Jun; 97(6):664; author reply 664-5.
Score: 0.062
-
Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008 Jun 17; 117(24):3118-25.
Score: 0.020
-
Pillemer SR, Brennan MT, Sankar V, Leakan RA, Smith JA, Grisius M, Ligier S, Radfar L, Kok MR, Kingman A, Fox PC. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome. Arthritis Rheum. 2004 Aug 15; 51(4):601-4.
Score: 0.016
-
Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, Baum BJ, Pillemer SR. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum. 2004 Jul; 50(7):2240-5.
Score: 0.016